NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.

Financials have performed very well already, particularly in Europe, but remain quite reasonably priced with NIMs rather resilient to rate cuts. In Japan, they are benefiting from greater investment and capital market activity. iShares Edge MSCI Intl Value Factor ETF has been a great way to avoid the major hit to portfolios from the significantly lower USD on a YTD basis.

Alphabet (GOOGL) stock has been on a tear. That run continued Monday.

House China Committee demands Amazon show country of origin for products before Black Friday. Company must respond by Dec. 15 on transparency reforms.

Tyson Foods will close its Nebraska beef plant affecting 3,200 workers and scale back Texas operations as cattle shortages force major industry restructuring.

Tonix Pharmaceuticals Holding Corp. received FDA approval and launched Tonmya, the first new fibromyalgia drug in over 15 years. TNXP is expanding Tonmya into acute stress disorder [ASD] and major depressive disorder [MDD], with key phase 2 trials underway or planned to initiate. The company maintains a strong cash position, supporting operations into 2027, but future capital raises may be needed to commercialize Tonmya and fund the rest of the TNXP pipeline.

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea.

Amazon.com is planning to invest about $15 billion in Northern Indiana to build data center campuses, the tech giant said as it looks to boost its cloud computing capacity to support booming artificial intelligence demand.

Circle Internet Group NYSE: CRCL, the fintech best known as the issuer of the stablecoin USDC, has been on a tumultuous share price path since going public in June.

BridgeBio Pharma Inc (NASDAQ:BBIO) stock is up 3.3% to trade at $70.36 at last check, and earlier hit a fresh four-year high $70.60 on a bounce off its 20-day moving average.

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, has been hit with a securities fraud class action lawsuit after its share price plummeted nearly 90% in a single day. The sharp decline was triggered by the release of disappointing Phase 3 trial results for its lead and only drug candidate, sonelokimab (SLK).

Grindr Inc (NYSE:GRND) shares fell more than 10% on Monday after the LGBTQ+ social networking platform said a proposal to take it private at a valuation of roughly $3.46 billion would not move forward, citing uncertainty around financing. The proposed buyout, led by major shareholders Ray Zage and James Lu, offered $18 per share in cash and represented a significant premium to Grindr's trading price when the offer was submitted on October 24.

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 17, 2025, James Hardie Industries plc (NYSE: JHX) announced the departure of its CFO (Rachel Wilson) who was immediately replaced by outsider Ryan Lada. This development follows the 34% August 20, 2025 collapse in James Hardie's share price and the class-action lawsuit filed against it and certain of its executives, alleging Defendants committed securities fraud by misleading investors about inventory levels and customer demand in its crucial North American segment.

Palantir Technologies Inc (NASDAQ: PLTR) spent most of 2025 absorbing heat for its valuation, but while the market argued about the multiple, the company quietly executed one of the most aggressive expansion streaks of any enterprise software player this year. In 10 months, Palantir stitched together 26 partnerships spanning 15 sectors, taking its business far beyond the defense-first label critics still cling to.

Celestica Inc (NYSE: CLS) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:55 AM EST on November 24, CLS triggered a Power Inflow signal at a price of $306.70. In the hour leading up to the Power Inflow signal, CLS's stock price had some slight pullback following the initial price rise that occurred earlier in the day.

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted by the recent departure of its Chief Revenue Officer (CRO). The company announced in a Form 8-K filing on November 4, 2025, that Rick Mahoney, who had served as CRO for three years, “will no longer serve as Synopsys' Chief Revenue Officer, effective immediately.

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA rejection letter. National shareholders rights firm Hagens Berman is actively investigating the alleged legal claims and urges Telix investors who suffered substantial losses to submit your losses now.

RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is December 26, 2025.

New York, New York--(Newsfile Corp. - November 24, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Firefly Aerospace securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet $9.93 (-24%) after the company announced that it fired CEO Bill Nash and issued its new Q3 2026 preliminary outlook on comparable store used unit sales, calling for a decline of 8%-12% from a year ago. The developments are the latest following CarMax's dismal Q2 2026 results, which drove the share price down $11.45 (-20%) on September 25, 2025.